Bookmark

Add to MyYahoo RSS

Celgene News

News on Celgene (Ticker: CELG) continually updated from thousands of sources around the net.

Wednesday | The Item

Two N.J. sentenced in insider-trading scheme

A former pharmaceutical executive who cooperated with prosecutors was sentenced Thursday to 16 months in prison for his role in an insider-trading ring that made $1.48 million from tips about several health-care companies, including Stryker Corp., which has operations in Mahwah.

Comment?

Related Topix: Medicine, Stryker, Medical Equipment, Healthcare Industry, Morris Plains, NJ, Biotech, Celgene

Wednesday | NorthJersey.com

Christie joins groundbreaking for new building at Celgene in Summit

Governor Christie Wednesday touted Celgene, a maker of cancer drugs, as an example of state government's successfully helping a private company grow.

Comment?

Related Topix: Biotech, Medicine, Celgene, Healthcare Industry, Chris Christie, US Governors, Representative Leonard Lance, US Politics, US News, Republican, US House of Representatives

Wednesday | Seeking Alpha

Gilead: This Baby Has Been Thrown Away With The Bathwater

The Biotech sector has been under severe pressure lately and it seems to make the "headlines" daily as the cause for so much of the NASDAQ weakness.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Financial Markets, Celgene, Amgen

Tue Apr 15, 2014

Silicon Alley Insider

Here's Data On The 50 Best Employers In America

For our second annual list of the 50 Best Employers in America , Business Insider used data gathered and crunched by PayScale to evaluate companies on pay and happiness.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Apr 14, 2014

Pharmaceutical Processing

Pfizer's Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts

Ian C. Read, chairman and CEO of Pfizer, Inc, was elected chairman of the Pharmaceutical Research and Manufacturers of America today at the trade association's annual meeting.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Merck , Biogen Idec

Seeking Alpha

Celgene Growth Unappreciated In Recent Sell-Off

Celgene Corporation is a top biopharmaceutical company currently involved in researching, developing, and commercializing products for treating chronic diseases such as cancer and other conditions related to immune systems and inflammatory problems.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

CNN

Hopes pinned on biotech firms' development of novel treatments

When it comes to biotech stocks, patience is the key. Investors need to hold on for the long-term while learning more about how their stocks will become more valuable in the future.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Amgen, Healthcare Industry, Gilead Sciences, Startups, Cancer, Health

Fri Apr 11, 2014

BioSpace

Pfizer Inc. CEO Takes On Additional Role, Becomes PhRMA Board Chairman

Pfizer's Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts WASHINGTON, Apr 11, 2014 -- Ian C. Read, chairman and CEO of Pfizer, Inc, was elected chairman of the Pharmaceutical Research and Manufacturers of America today at the trade association's annual meeting.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Merck , Biogen Idec

Seeking Alpha

3 Biotech Companies That Look To Be Good Buys After A Pullback

Though the biotech sector may be volatile there are a number of positive reasons that these three stocks should move higher.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Financial Markets, Startups, CGI Pharmaceuticals, Celgene

PR-inside.com

Globl orphan drugs market growth dampened by high costs of drug development

One of the key factors contributing to this market growth is the shorter development timelines.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Food and Drug Administration

Thu Apr 10, 2014

I-Newswire.com

Small Interest Rises As Biotechs Fall

In a period when many biotech stocks were slipping, short sellers moved on many of the leading biotech and emerging pharmaceuticals between the March 14 and March 31 settlement dates.

Comment?

Related Topix: Biotech, Science / Technology, Financial Markets, Medicine, Amgen, Healthcare Industry, Celgene

Wed Apr 09, 2014

BayStreet.ca

BlackBerry CEO May Consider Exiting Handset Business; Celgene...

Shares of Merck & Co. closed up 3.74% on Wednesday with about 16 million shares traded.

Comment?

Related Topix: Biotech, Medicine, Celgene, Healthcare Industry, Merck , Merck & Co., Financial Markets, Biomira

NorthJersey.com

Drug-merger insider trading scheme ends in jail for 2 NJ men

A federal judge on Wednesday ordered two New Jersey men to serve prison time for their admitted roles in a $1.48 million insider-trading scheme involving medical, technical and pharmaceutical companies.

Comment?

Related Topix: Livingston, NJ, Morris Plains, NJ, Newark, NJ, Biotech, Medicine, Healthcare Industry

Forbes.com

Wednesday Sector Leaders: Materials, Healthcare

The best performing sector as of midday Wednesday is the Materials sector, up 1.5%.

Comment?

Related Topix: Rubber-Plastics, Manufacturing, Industrial Machines, ATI, Startups, Goodyear Tire and Rubber, Financial Markets, Biotech, Medicine, Healthcare Industry, Regeneron Pharmaceuticals

TheStreet.com

Celgene Higher on Revlimid Patent Case Document Release

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Mozilla

Tue Apr 08, 2014

Hispanic Business

Edge Therapeutics Expands Senior Management Team and Opens New...

Edge Therapeutics, a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions, today announced the appointment and promotion of key executives to its senior management team ... (more)

Comment?

Related Topix: Biotech, Science / Technology, Medicine, Healthcare Industry

Mon Apr 07, 2014

Seeking Alpha

Celgene In Mylan's Cross-Hairs: "I'm Shakin' In My Boots"... Well, Maybe A Little

Mylan's actions are understandable, but success is questionable given its "litigious" history and the very nature of the business model.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry

Sun Apr 06, 2014

BayStreet.ca

Celgene Corporation Sued by Mylan Inc.; GRUBHUB Soars on its First...

GRUBHUB closed up 30.77% on nearly 11 million shares traded this past Friday, making it one of the biggest gainers on the NYSE.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Drugs, Visa

Fri Apr 04, 2014

Freshnews

BetterInvesting Magazine Releases June Stock To Study And Undervalued ...

The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Skyworks Solutions, Inc. as its June 2014 "Stock to Study" and Celgene Corporation as its June 2014 "Undervalued Stock" for investors' informational and educational use.

Comment?

Related Topix: Semiconductors, Skyworks Solutions, Electronics, Biotech, Medicine, Healthcare Industry, Celgene, Financial Markets

Barron's

Who Says There's No Biotech Bubble?

Biotech stocks are plunging today, which once again raises the question: Are we witnessing the popping of the biotech bubble ? It's hard not to think it might be.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups, CGI Pharmaceuticals, Intercept Pharmaceuticals

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••